A Gary Lyons

Affiliations

  • Director at Neurocrine Biosciences Inc (NBIX), 2021-10-12
  • Director at Brickell Biotech Inc. (BBI), 2021-06-14
  • Director at Rigel Pharmaceuticals Inc (RIGL), 2021-05-22
  • Director at Travere Therapeutics Inc. (TVTX), 2021-05-19
  • Director at Novus Therapeutics Inc. (NVUS), 2020-09-16
  • Director at Cytori Therapeutics Inc. (CTYX), 2018-02-09
  • Director at Kalobios Pharmaceuticals Inc (KBIO), 2015-07-14
  • Director at Neurogesx Inc (NGSX), 2012-06-12
  • Director at Poniard Pharmaceuticals Inc. (PARD), 2011-07-12
  • Director at Facet Biotech Corp (FACT), 2010-04-23
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
VICL $4.39 7,078 Director 14,906 2016-06-03 Filing
VICL $0.01 5,953 Director 63,281 2013-05-23 Filing
VICL $0.01 7,328 Director 57,328 2012-05-24 Filing
VICL $0.01 18,750 Director 50,000 2011-05-26 Filing
VICL $0.01 18,750 Director 31,250 2010-05-25 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
NBIX $105.06 5,000 Director 208,697 2021-10-07 Filing
NBIX $100.27 10,000 Director 213,697 2021-06-10 Filing
NBIX $120.00 400 Director 223,697 2021-01-26 Filing
NBIX $120.03 1,600 Director 224,097 2021-01-25 Filing
NBIX $110.00 5,000 Director 225,697 2019-11-08 Filing